IMMUNIC, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.22 USD | -3.17% |
|
+3.39% | -18.67% |
| 09/04 | Transcript : Immunic, Inc. - Special Call | |
| 21/03 | Immunic Gets US Patent Notice of Allowance For Specific Polymorph of Vidofludimus Calcium | MT |
Chart calendar Immunic, Inc.
f299ce6e2b5aec0d0e2.0uGYoIjh8S3vdaBxPo3ahHoqC4B6HmBFdGsQ7Im4Yrk.n5GsxuS0tEeWTM8bbd6y_SNsRc8uRBV1RTIniN79Ut3gq8GT2qaid6Qc8Q~b1b146f9be243d7084f362720a5ccda9
Upcoming events on Immunic, Inc.
Past events on Immunic, Inc.
| 18/04/2024 07:30 pm | Noble Capital Markets Emerging Growth Virtual Health Care Equity Conference |
| 15/04/2024 | Accelerating Bio-Innovation UK Conference |
| 09/04/2024 11:00 pm | R&D Day |
| 28/03/2024 03:30 pm | Society for Virology Meeting - Abstract Number: 73 |
| 25/03/2024 05:30 pm | Society for Virology Meeting - Abstract Number: 107 |
| 18/03/2024 09:30 pm | Frontiers in Medicinal Chemistry Confererence - Poster Session II |
| 17/03/2024 10:30 pm | Frontiers in Medicinal Chemistry Confererence - Poster Session I |
| 11/03/2024 | Leerink Partners Global Biopharma Conference |
| 06/03/2024 | Clinical Trial Supply Europe Conference |
| 06/03/2024 | Temperature Controlled Logistics In Biopharmaceuticals Europe Conference |
| 04/03/2024 08:30 pm | Extraordinary Shareholders Meeting |
| 01/03/2024 04:30 pm | ACTRIMS Forum - Abstract Number: 6 |
| 29/02/2024 04:30 pm | ACTRIMS Forum - Abstract Number: 509 |
| 22/02/2024 06:30 pm | Q4 2023 Earnings Call |
| 22/02/2024 05:00 pm | Q4 2023 Earnings Release |
| 08/02/2024 | BioCapital Europe Conference |
| 01/02/2024 | Genotoxicity and Nitrosamine Conference |
| 08/01/2024 | JPMorgan Healthcare Conference |
| 14/11/2023 06:30 pm | Q3 2023 Earnings Call |
| 14/11/2023 05:00 pm | Q3 2023 Earnings Release |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -37,0 -36,5 -1.39% | -49,0 -48,3 -1.35% | -75,4 -89,4 15.63% | -86,5 -81,9 -5.69% | -99,2 -98,8 -0.46% | -91,2 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 0,00 - | -44,0 -46,3 4.97% | -92,9 -91,0 -2.11% | -120 -83,8 -43.75% | -93,6 -94,7 1.14% | -90,8 |
|
Net income Million USD | Released Forecast Spread | 0,00 0,00 - | -44,0 -46,3 4.97% | -92,9 -90,8 -2.36% | -120 -91,1 -32.18% | -93,6 -95,4 1.87% | -93,0 |
|
EPS USD | Released Forecast Spread | 0,00 0,00 - | -2,81 -2,86 1.69% | -3,93 -3,89 -0.96% | -3,78 -2,90 -30.52% | -2,11 -2,14 1.52% | -0,99 |
| Announcement Date | 16/03/20 | 26/02/21 | 24/02/22 | 23/02/23 | 22/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -22,8 -19,4 -17.15% | -21,4 -21,7 1.31% | -20,6 -22,3 7.61% | -20,1 -19,9 -1.29% | -24,4 -19,7 -23.66% | -27,3 -20,9 -30.57% | -25,0 -22,3 -12.37% | -23,6 -24,0 1.97% | -23,4 -22,9 -2% | -22,2 | -22,5 | -22,9 | -23,7 | -26,5 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -21,2 -19,3 -10.05% | -20,8 -20,4 -1.86% | -21,9 -22,4 2.24% | -21,2 -20,0 -6.36% | -56,5 -19,8 -184.85% | -25,3 -21,0 -20.15% | -24,0 -22,3 -7.73% | -22,8 -23,8 4.4% | -21,6 -22,6 4.76% | -22,1 | -22,1 | -22,4 | -23,0 | -26,5 |
|
Net income Million USD | Released Forecast Spread | -21,2 -19,0 -11.26% | -20,8 -20,8 0.15% | -21,9 -22,2 1.13% | -21,2 -20,1 -5.34% | -56,5 -27,7 -104.24% | -25,3 -21,6 -16.86% | -24,0 -23,1 -3.86% | -22,8 -24,3 6.25% | -21,6 -23,4 7.66% | -22,4 | -22,6 | -23,2 | -23,8 | -26,5 |
|
EPS USD | Released Forecast Spread | -0,60 -0,76 21.05% | -0,74 -0,79 5.73% | -0,72 -0,72 -0.28% | -0,69 -0,66 -4.81% | -1,62 -0,74 -117.74% | -0,58 -0,52 -12.08% | -0,54 -0,53 -2.86% | -0,51 -0,55 6.85% | -0,48 -0,51 6.34% | -0,26 | -0,24 | -0,24 | -0,24 | -0,28 |
| Announcement Date | 24/02/22 | 10/05/22 | 04/08/22 | 03/11/22 | 23/02/23 | 11/05/23 | 03/08/23 | 14/11/23 | 22/02/24 | - | - | - | - | - |
More events
Past sector events for Immunic, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- IMUX Stock
- Calendar Immunic, Inc.
